Search Results for: Alize Pharma II Acquired by
Articles
November 18, 2013
MARKET BRIEF - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs November 18, 2013
Adam M. Dion, MS, summarizes GlobalData’s recent CRO Benchmark Report and believes the dynamics of pharmaceutical outsourcing and location decisions in emerging markets are changing. Cost reduction is being augmented and will gradually be eclipsed by footprint growth as a major factor shaping decisions, and CROs are realizing that the ability to be on the ground closer to their customers is a key building block to establishing sustainable, long-term relationships with clients.
October 2, 2013
EXECUTIVE INTERVIEW - Capsugel DFS: Integrating Technology for Innovative Finished Dosage Forms October 2, 2013
Drug Development Executive: Amit Patel, President of Capsugel’s Dosage Form Solutions business unit, speaks about the formulation challenges facing the industry and the increasing pressure on companies to remain competitive in today’s dynamic marketplace.
September 18, 2013
Roche & Inovio Enter $422.5-Million Licensing Deal September 18, 2013
Roche and Inovio Pharmaceuticals, Inc. recently announced they have entered into an exclusive worldwide license agreement to research, develop and...
June 25, 2013
Transition Therapeutics to Get $7 Million as Eli Lilly Assumes Rights to Diabetes Drug June 25, 2013
Transition Therapeutics Inc. recently announced that Eli Lilly and Company has exercised its option to assume all development and commercialization...
February 28, 2013
3/6/2013 February 28, 2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...
February 17, 2013
2/20/2013 February 17, 2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of...
January 27, 2013
1/30/2013 January 27, 2013
Baxter International Makes $700-Million Acquisition Inspiration Biopharmaceuticals and Ipsen recently announced the sale of its lead hemophilia program, OBI-1 (recombinant...
January 3, 2013
1/9/2013 January 3, 2013
Ultragenyx Secures $75 Million for Ultra-Rare Diseases Ultragenyx Pharmaceutical Inc. recently announced the successful completion of a $75-million Series B...
November 26, 2012
11/28/2012 November 26, 2012
CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...
November 19, 2012
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
October 1, 2012
10/3/2012 October 1, 2012
Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a...
September 3, 2012
9/5/2012 September 3, 2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human...
August 26, 2012
8/29/2012 August 26, 2012
Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb...
August 5, 2012
8/8/2012 August 5, 2012
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence...
July 19, 2012
7/25/2012 July 19, 2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was...
July 4, 2012
7/11/2012 July 4, 2012
RoundTable Healthcare Acquires DPT Laboratories RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently...
May 28, 2012
5/30/2012 May 28, 2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd....
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
March 29, 2012
4/3/2012 March 29, 2012
Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...
March 7, 2012
3/13/2012 March 7, 2012
Aegerion Pharmaceuticals Submits US & EU Marketing Applications Aegerion Pharmaceuticals, Inc. recently announced it has submitted an NDA to the...
